canadian pharma metformin
Metformin is one of the most widely used medications in Canada to treat type 2 diabetes. It belongs to a class of medications known as biguanides, which work by reducing glucose production in the liver and increasing insulin sensitivity in the body. Metformin has been shown to be an effective medication for controlling blood sugar levels and reducing the risk of complications associated with type 2 diabetes. In Canada, metformin is available in both immediaterelease and extendedrelease forms. The immediaterelease form is taken twice a day, while the extendedrelease form can be taken once daily. Metformin is typically prescribed at a starting dose of 500mg to 850mg per day, with adjustments made as needed based on blood sugar levels. One of the primary benefits of metformin is its ability to reduce the risk of cardiovascular complications associated with type 2 diabetes. Studies have shown that taking metformin can lower the risk of heart attacks, strokes, and other cardiovascular events by up to 20%. Additionally, metformin has been shown to slow the progression of kidney disease in people with type 2 diabetes. Metformin is also effective at reducing the risk of cancer in people with type 2 diabetes. A study published in the journal Cancer Research found that taking metformin for at least three years reduced the risk of developing colon cancer by up to 40%. Another study published in the Journal of Clinical Oncology found that metformin reduced the risk of lung cancer in people with type 2 diabetes. Metformin is generally welltolerated and has a low risk of serious side effects. Common side effects include stomach upset, diarrhea, and headache. However, more serious side effects can occur, such as lactic acidosis, which is a rare but potentially lifethreatening condition that occurs when metformin builds up in the body. It is important to note that metformin should not be used during pregnancy or breastfeeding without consulting a healthcare provider. Additionally, people with certain medical conditions, such as kidney disease, may need to take a lower dose of metformin or have their blood sugar levels closely monitored. In conclusion, metformin is an effective and widely used medication in Canada for treating type 2 diabetes. It has been shown to reduce the risk of cardiovascular complications, slow the progression of kidney disease, and reduce the risk of certain types of cancer. While it is generally welltolerated, it is important to discuss any concerns or side effects with a healthcare provider. As a doctor, I recommend that patients with type 2 diabetes talk to their healthcare provider about using metformin as part of their treatment plan. With proper monitoring and adjustment of dosage, metformin can be a safe and effective medication for controlling blood sugar levels and reducing the risk of complications associated with type 2 diabetes. By working closely with your healthcare provider, you can help manage your condition effectively and improve your overall health.
